Melissa A Jackson

38PUBLICATIONS
116CO-AUTHORS
Access to justiceCounselling psychologyToxicology (incl. clinical toxicology)Clinical neuropsychologyPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (38)

|Aug 04, 2026
Long-Acting Injectable Buprenorphine in Prison: Insights From a Short-Answer Survey of People in the Criminal Justice System Commencing Long-Acting Injectable Buprenorphine During a Non-Randomised Clinical Trial.

|Jul 30, 2026
Quitline Counsellors' Experiences With Vaping and Nicotine Replacement Therapy for Smoking Cessation in Australian Drug and Alcohol Services.

|Feb 19, 2026
Experiences of People Who Discontinue Long-Acting Injectable Buprenorphine Treatment Recently Released From Prison in New South Wales, Australia.

Lucy J D Peck, Bethany White, Maja Moensted

|Feb 11, 2026
Risk Factors for Cognitive Impairment in Adults Attending Australian Community-Based Substance Use Treatment Services.

Nicole Ridley, Ashley Wheeler, Heather M Francis

|Jan 26, 2026
Expanding Access to Addiction Medicine Specialist Care in Regional New South Wales, Australia Through Telehealth.

Clare S Smylie, Carl I Moller, Lucy McWilliams

|Sep 02, 2025
Buvidal/Brixadi - a long-acting injectable buprenorphine formulation for the treatment of opioid dependence.

Nicholas Lintzeris, Adrian J Dunlop

Pageof 7

Frequent Collaborators

17 joint publications

Nicholas Lintzeris

6 joint publications

Nadine Ezard

5 joint publications

Bethany White

5 joint publications

Amanda L Baker